Abstract
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are both caused by mutations in DMD gene effecting the expression of dystrophin. Generally female carriers are asymptomatic; however, it has been suggested that carriers may exhibit symptoms. We investigated a 6-year-old Chinese girl exhibiting a suspected BMD phenotype, including persistently elevated creatine kinase and creatine kinase isoenzyme levels. The proband harbored a novel heterozygous mutation, c.3458_3459insAA, within exon 26 of the DMD gene inherited from her mother who had a completely normal phenotype and presented with mosaicism in her lymphocytes with 45, X [17%]/46, XX [83%]. In addition, X-chromosome inactivation (XCI) patterns in the peripheral blood of the child were slightly skewed: proband with 62% (mutant allele)/38% (normal allele) when compared with her mother with 32/68%. Amplification of regions of the cDNA revealed different ratios for the expression of these alleles: proband with 50/50% and her mother with 20/80%. Real-time PCR showed that mRNA expression was significantly decreased in both. We proposed that a frameshift or nonsense mutation may contribute to the development of symptoms in carriers. These phenotypes correlate with nonrandom XCI patterns and are compounded by the locus of the mutation. For incompletely skewed XCI patterns, although the mutant allele could suppress the expression of a normal allele, carriers would remain asymptomatic as long as there was adequate compensation from the normal allele. We also proposed a mechanism where mRNA from the mutant allele may be unstable and easily degraded, allowing for phenotypic compensation by the wildtype allele.
Similar content being viewed by others
References
Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW (1992) Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229–1239
Bittel DC, Theodoro MF, Kibiryeva N, Fischer W, Talebizadeh Z, Butler MG (2008) Comparison of X-chromosome inactivation patterns in multiple tissues from human females. J Med Genet 45:309–313
Bolduc V, Chagnon P, Provost S, Dubé M-P, Belisle C, Gingras M, Mollica L, Busque L (2008) No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans. J Clin Investig 118:333–341
Boyd Y, Buckle V, Holt S, Munro E, Hunter D, Craig I (1986) Muscular dystrophy in girls with X; autosome translocations. J Med Genet 23:484–490
Deepha S, Vengalil S, Preethish-Kumar V, Polavarapu K, Nalini A, Gayathri N, Purushottam M (2017) MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India. BMC Med Genet 18:67
Goodfellow PJ, Mondello C, Darling SM, Pym B, Little P, Goodfellow PN (1988) Absence of methylation of a CpG-rich region at the 5′ end of the MIC2 gene on the active X, the inactive X, and the Y chromosome. Proc Natl Acad Sci USA 85:5605–5609
Ishizaki M, Kobayashi M, Adachi K, Matsumura T, Kimura E (2018) Female dystrophinopathy: review of current literature. Neuromuscul Disord 28:572–581
Juan-Mateu J, Gonzalez-Quereda L, Rodriguez MJ, Baena M, Verdura E, Nascimento A, Ortez C, Baiget M, Gallano P (2015) DMD mutations in 576 dystrophinopathy families: a step forward in genotype–phenotype correlations. PLoS ONE 10:e0135189
Kiedrowski LA, Raca G, Laffin JJ, Nisler BS, Leonhard K, McIntire E, Mongomery KD (2011) DNA methylation assay for X-chromosome inactivation in female human iPS cells. Stem Cell Rev Rep 7:969–975
Liu X-Y, Zhang H-G, Chen S, Wang R-X, Zhang Z-H, Liu R-Z (2013) 45,X mosaicism in northeast China: a clinical report and review of the literature. J Assist Reprod Genet 30:407–412
Matthews PM, Benjamin D, Van Bakel I, Squier MV, Nicholson LV, Sewry C, Barnes PR, Hopkin J, Brown R, Hilton-Jones D, Et A (1995) Muscle X-inactivation patterns and dystrophin expression in Duchenne muscular dystrophy carriers. Neuromuscul Disord 5:209–220
Mercier S, Toutain A, Toussaint A, Raynaud M, de Barace C, Marcorelles P, Pasquier L, Blayau M, Espil C, Parent P, Journel H, Lazaro L, Andoni UJ, Moerman A, Faivre L, Eymard B, Maincent K, Gherardi R, Chaigne D, Ben YR, Leturcq F, Chelly J, Desguerre I (2013) Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age. Eur J Hum Genet 21:855–863
Norman A, Harper P (1989) A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales. Clin Genet 36:31–37
Orstavik KH (2009) X chromosome inactivation in clinical practice. Hum Genet 126:363–373
Papa R, Madia F, Bartolomeo D, Trucco F, Pedemonte M, Traverso M, Broda P, Bruno C, Zara F, Minetti C, Fiorillo C (2016) Genetic and early clinical manifestations of females heterozygous for Duchenne/Becker muscular dystrophy. Pediatr Neurol 55:58–63
Quan F, Janas J, Toth-Fejel S, Johnson DB, Wolford JK, Popovich BW (1997) Uniparental disomy of the entire X chromosome in a female with Duchenne muscular dystrophy. Am J Hum Genet 60:160–165
Richards CS, Watkins SC, Hoffman EP, Schneider NR, Milsark IW, Katz KS, Cook JD, Kunkel LM, Cortada JM (1990) Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy. Am J Hum Genet 46:672–681
Satre V, Monnier N, Devillard F, Amblard F, Lunardi PJ (2004) Prenatal diagnosis of DMD in a female foetus affected by Turner syndrome. Prenat Diagn 24:913–917
Seemann N, Selby K, McAdam L, Biggar D, Kolski H, Goobie S, Yoon G, Campbell C (2011) Symptomatic dystrophinopathies in female children. Neuromuscul Disord 21:172–177
Soltanzadeh P, Friez MJ, Dunn D, von Niederhausern A, Gurvich OL, Swoboda KJ, Sampson JB, Pestronk A, Connolly AM, Florence JM, Finkel RS, Bönnemann CG, Medne L, Mendell JR, Mathews KD, Wong BL, Sussman MD, Zonana J, Kovak K, Gospe SM, Gappmaier E, Taylor LE, Howard MT, Weiss RB, Flanigan KM (2010) Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord 20:499–504
Taylor PJ, Maroulis S, Mullan GL, Pedersen RL, Baumli A, Elakis G, Piras S, Walsh C, Prósper-Gutiérrez B, De La Puente-Alonso F, Bell CG, Mowat DR, Johnston HM, Buckley MF (2007) Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy. J Med Genet 44:368–372
Viggiano E, Picillo E, Cirillo A, Politano L (2013) Comparison of X-chromosome inactivation in Duchenne muscle/myocardium-manifesting carriers, non-manifesting carriers and related daughters. Clin Genet 84:265–270
Viggiano E, Ergoli M, Picillo E, Politano L (2016) Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy. Hum Genet 135:685–698
Yoshioka M, Yorifuji T, Mituyoshi I (1998) Skewed X inactivation in manifesting carriers of Duchenne muscular dystrophy. Clin Genet 53:102–107
Funding
This work was supported by a grant from the National Natural Science Foundation of China (31970558), the Natural Science Foundation of Guangdong Province (2018B030311033), the Science and Technology Program of Guangzhou (201707010301) and the Foundation of President of Nanfang Hospital (2018B003).
Author information
Authors and Affiliations
Contributions
FX and X-MX initiated the study FX and HZ designed and oversaw the entire project. CZ recruited patients and performed clinical evaluation and sample collection. J-FC, Z-JW and JW performed function analysis. J-FC prepared the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest. This study involved Human Participants, and was approved by the Southern University ethics committee. Informed consent was obtained from patients and relatives before analysis.
Additional information
Communicated by Stefan Hohmann.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, J., Zheng, H., Wang, Z. et al. A female carrier of a novel DMD mutation with slightly skewed X-chromosome inactivation shows a suspected case of Becker muscular dystrophy in a Chinese family. Mol Genet Genomics 296, 541–549 (2021). https://doi.org/10.1007/s00438-020-01757-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00438-020-01757-8